About Us
Founded in 1987, AMDL
is a US-based pharmaceutical company with major operations in
China. Our corporate headquarters are located in Tustin, California
and we have major research, development and manufacturing facilities
in both the US and “The People’s Republic of China”.
In partnership with our China-based subsidiary Jade Pharmaceutical,
Inc. (“JPI”), we develop and deliver innovative and therapeutic
diagnostic, pharmaceutical, cosmetic products worldwide. This
includes our proprietary and USFDA-approved AMDL ELISA DR-70 (FDP)
non-invasive, in vitro diagnostic cancer blood test, Combination
Immunogene Therapy cancer vaccine and best-selling Goodnak® anti-aging
cosmetic and therapeutic skin care line.
AMDL is listed on the American Stock Exchange Alternext US under
the symbol (“ADL”). In 2007, AMDL earned $15 million in revenues
– achieving over 100% YOY growth in gross revenues for the third
consecutive year. AMDL employs approximately 490 people primarily
in the US and China.